Natália Floriano Paiva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natália Floriano Paiva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Fabiana Testa Moura de Carvalho Vicentini
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-903, SP, Brazil
5 shared publications - Maíra Peres Ferreira
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
4 shared publications - Osvaldo de Freitas
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
3 shared publications - Amanda Marante Gimenez
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
2 shared publications - Isabella Kriunas Demonari
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
2 shared publications - Wendy Martin Rios
Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
2 shared publications
Latest Publications
- 28 October 2025
- Published by Springer Nature in Molecular Biotechnology
- Vol. 68 (5) , 2072-2087
Physical and Chemical Methods for DNA Vaccine Delivery: Insights into the Melanoma Landscape
Melanoma is a type of cancer that originates in melanocytes with high malignancy, mainly because the cancer cells can spread through the body and cause metastasis. It is projected that the annual incidence of melanoma will increase by over 50% between 2020 and 2040. DNA vaccines have been explored for the treatment and prevention of various globally important diseases and are a promising resource for melanoma. Generally, DNA vaccines are classified as third-generation vaccines, which consist of DNA plasmids encoding target antigens. Therefore, their mechanism of action involves delivering one or more genes of interest into host cells, triggering an immune response against the target antigen. In summary, the DNA vaccine must enter the cell cytoplasm and migrate to the nucleus to initiate replication, transcription, and production of the target antigen. Despite their many advantages, DNA constructs produce low levels of antigens in vivo due to the challenges in effectively activating an immune response. This review addresses general aspects relevant to the application of DNA vaccines in the landscape of melanoma treatment, focusing mainly on physical and chemical methods used to enhance DNA-based vaccines, considering key aspects of technology, advantages, limitations, applications, and the evolution of clinical translation.
- 28 October 2025
- Published by Springer Nature in Molecular Biotechnology
- Vol. 68 (5) , 2072-2087
Physical and Chemical Methods for DNA Vaccine Delivery: Insights into the Melanoma Landscape
Melanoma is a type of cancer that originates in melanocytes with high malignancy, mainly because the cancer cells can spread through the body and cause metastasis. It is projected that the annual incidence of melanoma will increase by over 50% between 2020 and 2040. DNA vaccines have been explored for the treatment and prevention of various globally important diseases and are a promising resource for melanoma. Generally, DNA vaccines are classified as third-generation vaccines, which consist of DNA plasmids encoding target antigens. Therefore, their mechanism of action involves delivering one or more genes of interest into host cells, triggering an immune response against the target antigen. In summary, the DNA vaccine must enter the cell cytoplasm and migrate to the nucleus to initiate replication, transcription, and production of the target antigen. Despite their many advantages, DNA constructs produce low levels of antigens in vivo due to the challenges in effectively activating an immune response. This review addresses general aspects relevant to the application of DNA vaccines in the landscape of melanoma treatment, focusing mainly on physical and chemical methods used to enhance DNA-based vaccines, considering key aspects of technology, advantages, limitations, applications, and the evolution of clinical translation.
- 6 September 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (11) , 103985
Production of apoferritin/chitosan complex by Maillard reaction as a promising platform to enhance pDNA delivery
- 6 September 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (11) , 103985
Production of apoferritin/chitosan complex by Maillard reaction as a promising platform to enhance pDNA delivery
- 18 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-18
Ferritin-Based Systems as a Platform for DNA Construct Delivery: Preparation, Characterization, and In Vitro Evaluation
- 18 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-18
Ferritin-Based Systems as a Platform for DNA Construct Delivery: Preparation, Characterization, and In Vitro Evaluation
- 28 November 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 206, 114589
Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation
- 28 November 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 206, 114589
Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation
- Open Access
- 4 November 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (11) , 2583
The Potential of Films as Transmucosal Drug Delivery Systems
Pharmaceutical films are polymeric formulations used as a delivery platform for administration of small and macromolecular drugs for local or systemic action. They can be produced by using synthetic, semi-synthetic, or natural polymers through solvent casting, electrospinning, hot-melt extrusion, and 3D printing methods, and depending on the components and the manufacturing methods used, the films allow the modulation of drug release. Moreover, they have advantages that have drawn interest in the development and evaluation of film application on the buccal, nasal, vaginal, and ocular mucosa. This review aims to provide an overview of and critically discuss the use of films as transmucosal drug delivery systems. For this, aspects such as the composition of these formulations, the theories of mucoadhesion, and the methods of production were deeply considered, and an analysis of the main transmucosal pathways for which there are examples of developed films was conducted. All of this allowed us to point out the most relevant characteristics and opportunities that deserve to be taken into account in the use of films as transmucosal drug delivery systems.
- 4 November 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (11) , 2583
Open AccessThe Potential of Films as Transmucosal Drug Delivery Systems
Pharmaceutical films are polymeric formulations used as a delivery platform for administration of small and macromolecular drugs for local or systemic action. They can be produced by using synthetic, semi-synthetic, or natural polymers through solvent casting, electrospinning, hot-melt extrusion, and 3D printing methods, and depending on the components and the manufacturing methods used, the films allow the modulation of drug release. Moreover, they have advantages that have drawn interest in the development and evaluation of film application on the buccal, nasal, vaginal, and ocular mucosa. This review aims to provide an overview of and critically discuss the use of films as transmucosal drug delivery systems. For this, aspects such as the composition of these formulations, the theories of mucoadhesion, and the methods of production were deeply considered, and an analysis of the main transmucosal pathways for which there are examples of developed films was conducted. All of this allowed us to point out the most relevant characteristics and opportunities that deserve to be taken into account in the use of films as transmucosal drug delivery systems.